Cryo-Cell International, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Description of Business, Basis of Presentation and Significant Accounting Policies - Additional Information (Detail)

Description of Business, Basis of Presentation and Significant Accounting Policies - Additional Information (Detail)				1 Months Ended	3 Months Ended		9 Months Ended
	Jun. 11, 2018	Jun. 01, 2017 USD ($)	Feb. 01, 2012 USD ($)	Dec. 31, 2005 USD ($)	Aug. 31, 2023 USD ($)	Aug. 31, 2022 USD ($)	Aug. 31, 2023 USD ($) Unit	Aug. 31, 2022 USD ($)
Business, Basis of Presentation and Significant Accounting Policies [Line Items]
Deferred revenue					$ 49,662,680		$ 49,662,680
Warranty payment		$ 100,000	$ 75,000	$ 50,000
Commission paid					10,061	$ 11,151	31,451	$ 38,471
Additional capitalized contract acquisition costs, net of amortization expense					30,185	29,269	85,133	81,028
Impairment of contract assets					0		0
Uncertain tax provisions					0		0
Provisions for interest or penalties related to uncertain tax positions							0	0
Impairment on long lived assets					0	0	0	0
Stock-based option compensation expense					172,099	161,083	641,690	310,441
Unrealized Gain Loss on Marketable Securities					93,386	(11,627)	100,082	(38,457)
Gain on interest rate swap					$ 282,731	$ 62,835	$ 58,757	$ 62,835
Payment warranty				$ 50,000
Increased payment warranty		$ 100,000	$ 75,000
Cord:Use [Member]
Business, Basis of Presentation and Significant Accounting Policies [Line Items]
Acquisition date	Jun. 11, 2018
Duke University [Member]
Business, Basis of Presentation and Significant Accounting Policies [Line Items]
Contracted storage amortization period					16 years		16 years
Umbilical Cord Blood and Cord Tissue Stem Cell Service and PrepaCyte-CB [Member] \| Duke University [Member]
Business, Basis of Presentation and Significant Accounting Policies [Line Items]
Agreement expiration date							Jan. 31, 2025
Inventory, in units \| Unit							6,000
Number of units, per month \| Unit							36
Maximum [Member] \| Umbilical Cord Blood and Cord Tissue Stem Cell Service and PrepaCyte-CB [Member] \| Duke University [Member]
Business, Basis of Presentation and Significant Accounting Policies [Line Items]
Inventory, in units \| Unit							36
Accounts Receivables [Member]
Business, Basis of Presentation and Significant Accounting Policies [Line Items]
Period of doubtful for accounts receivable due from client							30 days
Option One [Member]
Business, Basis of Presentation and Significant Accounting Policies [Line Items]
Contracted storage amortization period					21 years		21 years
Option Two [Member]
Business, Basis of Presentation and Significant Accounting Policies [Line Items]
Contracted storage amortization period					1 year		1 year
Option Three [Member]
Business, Basis of Presentation and Significant Accounting Policies [Line Items]
Contracted storage amortization period							life-time
Contracted storage amortization description							The life-time storage plan is based on a life expectancy of 81 years, which is the current estimate by the Center for Disease Control for United States women’s life expectancy and concluded that additional data analysis would result in an immaterial difference in revenue.